The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation.

Front Oncol · 2021 · PMC8374104 · PMID 34422653

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

showed a trendP=0.052so close (0.05 < p ≤ 0.1)

However, only the patients with TP53 mutations had a significantly increased probability of shorter OS (P=0.034) and PFS (P=0.011), and patients with DNMT3A mutations showed a trend toward shorter PFS (P=0.052).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.